Kevin K. Gordon
Director · Progyny, Inc.
IndividualSelling only
- 2025
- Sep 18, 2026
- 6
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kevin K. Gordon files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Peter Anevski - $1.93M in PGNY purchases and sales in the last 12 months
- Mark S. Livingston - $831K in PGNY purchases and sales in the last 12 months
- Allison Swartz - $402K in PGNY purchases and sales in the last 12 months
- Melissa B. Cummings - $310K in PGNY purchases and sales in the last 12 months
- Cheryl Scott - $196K in PGNY purchases and sales in the last 12 months
- Geoffrey Clapp - $39K in PGNY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kevin K. Gordon?
Kevin K. Gordon is a corporate insider, tracked as Director of Progyny, Inc. (PGNY). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kevin K. Gordon submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Kevin K. Gordon been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($826K) across all tracked filings.
